Conbercept efficacious in short-term treatment of Diabetic Macular Edema with or without Diabetic Nephropathy Dr Riya Dave20 Feb 2024 2:45 PM ISTDiabetic macular edema (DME) is a common complication of diabetes, and when coupled with diabetic nephropathy (DN), it poses additional challenges to...
Bayer Eylea 8 mg gets Japanese marketing nod Ruchika Sharma21 Jan 2024 1:00 PM ISTBerlin: Bayer has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted market authorization for Eylea 8 mg...
Sun Pharma Gets CDSCO Panel Nod for Additional Indication of Ranibizumab solution for injection Dr. Divya Colin16 Jan 2024 6:00 PM ISTNew Delhi: In line with the proposal presented by the drug major Sun Pharma, the Subject Expert Committee (SEC) functional under the Central Drug...
Bayer Eylea 8 mg approved in EU for treatment of two major retinal diseases Ruchika Sharma11 Jan 2024 3:30 PM ISTBerlin: Bayer has announced that the European Commission has granted marketing authorization in the European Union (EU) for new Eylea 8 mg...
Faricimab outperforms anti-VEGF Drugs in DME and AMD Treatment by improving central subfoveal thickness Aditi5 Jan 2024 10:45 PM ISTIn the industrialized world, Neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME) cause blindness. Faricimab, launched...
Brolucizumab Shows Promising Outcomes for Diabetic Macular Edema Care Jacinthlyn Sylvia3 Dec 2023 6:00 PM ISTAn update of a 52-week clinical trial unveiled promising results of brolucizumab compared to the standard aflibercept in enhancing diabetic macular...
Brolucizumab as good as aflibercept for improving clinical outcomes in Diabetic Macular Edema Outcomes: JAMA Jacinthlyn Sylvia19 Nov 2023 5:00 PM ISTA recent 52-week phase 3 clinical trial published in the Journal of American Medical Association compared the efficacy and safety of brolucizumab...
Bayer Aflibercept 8 mg recommended for approval in EU Ruchika Sharma15 Nov 2023 1:00 PM ISTBerlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a...
Lupin collaborate with Amman Pharma for marketing, commercialization of Ranibizumab in Middle East region Ruchika Sharma11 Nov 2023 10:00 AM ISTMumbai: Global Pharma major Lupin Limited has partnered with Amman Pharmaceuticals Industries, a pharmaceutical manufacturer with operations across...
Roche gets CDSCO panel Nod To study safety, and efficacy of Faricimab Intravitreal injection Dr. Divya Colin29 Oct 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Long-term Anti-VEGF Therapy for Diabetic Macular Edema Linked to Declining Renal Function Dr. Kamal Kant Kohli27 Sept 2023 8:00 PM ISTLong-term treatment with intravitreal anti-vascular endothelial growth factor (VEGF) therapy may be associated with a continuous decline in estimated...
Levosulpiride Shows Potential of Treating Diabetic Eye Conditions Jacinthlyn Sylvia24 Sept 2023 8:00 PM ISTA recent study published in the Eye Journal that the prokinetic drug levosulpiride may hold significant promise in the treatment of diabetic eye...
